Hugh Hempel is a technology industry veteran turned health care entrepreneur. In this moving talk he discusses how medicinal cannabis has enriched the lives of his ailing 11 year-old daughters. This talk will challenge your views of medical marijuana.
In 2006, Hugh’s 10 year old identical twin daughters were diagnosed with a rare and fatal neurodegenerative disease called Niemann Pick Type C, often referred to as “Childhood Alzheimer’s.”
In 2009, Hugh and his wife Chris became interested in Cannabidiol (CBD), one of at least 80 active cannabinoids identified in marijuana and hemp, as his twins suffer from intractable seizures as a result of their disease and experience up to a 100 seizures a week.
Through extensive research, they learned that cannabinoid receptors are involved in a vast array of functions in the body, including helping to control brain and nerve activity (including memory and pain), energy metabolism, heart function, and the immune system. After realizing pharmaceutical grade cannabis products were unavailable for their daughters and other patients in Nevada, the Hempel’s decided to create a Nevada based “cannabusiness” focused on legally developing and distributing high-quality flowers, extracts and concentrates at competitive prices.
You can listen to his fascinating story below.
